-+ 0.00%
-+ 0.00%
-+ 0.00%

SERES THERAPEUTICS - SER-155 WELL TOLERATED WITH NO DRUG-RELATED SERIOUS ADVERSE EVENTS THROUGH DAY 43

Reuters·07/08/2026 11:00:01

Please log in to view news